The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Mutant HRAS as novel target for MEK and mTOR inhibitors.

Michael  Kiessling

No Relationships to Disclose

Alessandra  Curioni Fontecedro

No Relationships to Disclose

Panagiotis  Samaras

No Relationships to Disclose

Michael  Scharl

No Relationships to Disclose

Gehard  Rogler

Honoraria - Abbott Laboratories; Abbvie; AstraZeneca; MSD; Vifor Pharma

Consulting or Advisory Role - Abbott Laboratories; Abbvie; Boehringer Ingelheim; Ferring; Genentech; Novartis; Pfizer; Roche Pharma AG; Takeda

Research Funding - Abbott Molecular (Inst); Abbvie (Inst); Calypso Medical (Inst); Flamentera AG (Inst); Novartis (Inst); Roche Pharma AG (Inst); Takeda (Inst)